| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, General Counsel | EVP, General Counsel
1 company
Krasney Karen serves as an EVP, General Counsel at CAPR. Across recent SEC filings that breaks down to 2 buys and 3 sells. Those positions are worth an estimated $215K at current prices.
The biggest single holding is CAPR (~$215K) as EVP, General Counsel. The recent filings there lean toward selling, a net 13,844 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | CAPR Capricor Therapeutics, Inc. | EVP, General Counsel | Sale+OE | 24,100 | $30.38 | $732,158.00 | -44.1% | - | - | |
| Jun 24, 2026 | CAPR Capricor Therapeutics, Inc. | EVP, General Counsel | Sale+OE | 900 | $30.00 | $27,000.00 | -1.5% | - | - | |
| Mar 16, 2016 | CAPR Capricor Therapeutics, Inc. | EVP, General Counsel | Buy | 4,060 | $2.40 | $9,744.00 | +57.2% | - | - | |
| Jan 21, 2015 | CAPR Capricor Therapeutics, Inc. | EVP, General Counsel | Buy | 7,096 | $3.52 | $24,999.21 | New | - | - |